Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Vibhav Varshney"'
Autor:
Geetanjali Singh, Vibhav Varshney, Ahsas Goyal, Nemat Ali, Muzaffar Iqbal, Ishnoor Kaur, Celia Vargas-De-La-Cruz, Tapan Behl
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e22052- (2023)
Background: Ischemic preconditioning (IPC) is the utmost capable design to achieve protection over ischemia-reperfusion injury (I/R), but this phenomenon gets attenuated during various pathological conditions like diabetes. Chrysin exhibits cardiopro
Externí odkaz:
https://doaj.org/article/a2a7da13e0db47489e8677249d1424cb
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 6, Iss 3, Pp 416-421 (2022)
Background: Diabetes decreased cardioprotective potential of ischemic postconditioning (IPOC), atrial natriuretic peptide (ANP) induced the cardioprotection against ischemic-reperfusion (I/R) injury. The present study has been designed to investigate
Externí odkaz:
https://doaj.org/article/1a5381ee3040456592fe4ccd9078821c
Publikováno v:
Pharmacognosy Research. 15:235-241
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80e13c2e2f90b201986b04b69a229f52
https://doi.org/10.5530/pres.15.2.025
https://doi.org/10.5530/pres.15.2.025
Autor:
Vibhav Varshney, Debapriya Garabadu
Publikováno v:
Molecular Biology Reports. 48:4319-4331
Alzheimer’s disease (AD) is a neurodegenerative disorder with cognitive deficits in an individual. Ang(1–7) exhibits neuroprotection against amyloid beta (Aβ)-induced mitochondrial dysfunction and neurotoxicity in experimental conditions. Furthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d9e3a76025f8ce95ba7fe58b899463
https://doi.org/10.1007/s11033-021-06447-1
https://doi.org/10.1007/s11033-021-06447-1
Autor:
Vibhav Varshney, Debapriya Garabadu
Publikováno v:
Neurotoxicity Research. 39:1023-1043
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with clinical manifestation of loss in cognitive functions in an individual. Though several drug candidates have been developed in the management of AD, an alternative option is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a359dbfcd75f2be6efee8cd1f748a55a
https://doi.org/10.1007/s12640-021-00336-y
https://doi.org/10.1007/s12640-021-00336-y
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 54:690-697
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10c3e5614922681b2645cc55d50e9f17
https://doi.org/10.5530/ijper.54.3.119
https://doi.org/10.5530/ijper.54.3.119
Autor:
Vibhav, Varshney, Debapriya, Garabadu
Publikováno v:
Neurotoxicity researchReferences. 39(4)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with clinical manifestation of loss in cognitive functions in an individual. Though several drug candidates have been developed in the management of AD, an alternative option is sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::148b2878bee707f0523e602207fa8d2e
https://pubmed.ncbi.nlm.nih.gov/33534126
https://pubmed.ncbi.nlm.nih.gov/33534126
Autor:
Vibhav Varshney, Debapriya Garabadu
Publikováno v:
Neuropeptides. 86
Renin Angiotensin System plays significant role in the memory acquisition and consolidation apart from its hemodynamic function in the pathophysiology of Alzheimer's disease (AD). It has been reported that Ang (1–7) ameliorates the cognitive impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99715d86ea2e1892e4dc94b0f5317c58
https://pubmed.ncbi.nlm.nih.gov/33508525
https://pubmed.ncbi.nlm.nih.gov/33508525
Publikováno v:
Biomedical and Biotechnology Research Journal (BBRJ). 6:416
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa973a58abac7f62e119d8ed53ae165a
https://doi.org/10.4103/bbrj.bbrj_90_22
https://doi.org/10.4103/bbrj.bbrj_90_22
Publikováno v:
Journal of Indian College of Cardiology. 7:72-77
Objective Ischemic postconditioning (IPOC) is an endogenous cardioprotective phenomenon, which gets attenuated during the hyperlipidemia. It has been documented that erythropoietin (EPO), a glycoprotein, produces IPOC-like cardioprotection through co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeb181a255dcc0f1039f701c0e6f681e
https://doi.org/10.1016/j.jicc.2017.03.003
https://doi.org/10.1016/j.jicc.2017.03.003